A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
In order to apply human embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs) to regenerative medicine, the cells should be produced under restricted conditions conforming to GMP guidelines. Since the conventional culture system has some issues that need to be addressed to achieve this goal, we developed a novel culture system. We found that recombinant laminin-511 E8 fragments are useful matrices for maintaining hESCs and hiPSCs when used in combination with a completely xeno-free (Xf) medium, StemFit™. Using this system, hESCs and hiPSCs can be easily and stably passaged by dissociating the cells into single cells for long periods, without any karyotype abnormalities. Human iPSCs could be generated under feeder-free (Ff) and Xf culture systems from human primary fibroblasts and blood cells, and they possessed differentiation abilities. These results indicate that hiPSCs can be generated and maintained under this novel Ff and Xf culture system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The use of defined culture media with recombinant proteins instead of whole animal serum greatly increases process comparability and supply chain assurance [67,68,69].”
From Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies (2023) · cites this paper as [68]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Gene-modified therapies, including iPSC-derived products and CAR-T cells, present distinct biosafety and technical challenges for POC implementation (Nakagawa et al., 2014; Moradi et al., 2023).”
From Isolator-based point-of-care manufacturing: a practical solution for GMP-compliant cell and extracellular vesicles therapy production (2025) · cites this paper as Nakagawa et al., 2014
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Self-citationInduction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Self-citationEmbryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,926
Generation of germline-competent induced pluripotent stem cells
Okita, K., Ichisaka, T., & Yamanaka, S. (2007) · Nature · doi:10.1038/nature05934 · Cited by 4,299
Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts
Nakagawa, M., Koyanagi, M., Tanabe, K., Takahashi, K., Ichisaka, T., Aoi, T., Okita, K., Mochiduki, Y., Takizawa, N., & Yamanaka, S. (2008) · Nature Biotechnology · doi:10.1038/nbt1374 · Cited by 2,380
A more efficient method to generate integration-free human iPS cells
Okita, K., Matsumura, Y., Sato, Y., Okada, A., Morizane, A., Okamoto, S., Hong, H., Nakagawa, M., Tanabe, K., Tezuka, K.-I., et al. (2011) · Nature Methods · doi:10.1038/nmeth.1591 · Cited by 2,061 · cited 3×
“Moreover, hiPSCs were successfully established from primary fibroblasts, peripheral blood and cord blood under these conditions using episomal vectors 16,17 .”
BackgroundMethodA ROCK inhibitor permits survival of dissociated human embryonic stem cells
Watanabe, K., Ueno, M., Kamiya, D., Nishiyama, A., Matsumura, M., Wataya, T., Takahashi, J. B., Nishikawa, S., Nishikawa, S.-I., Muguruma, K., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1310 · Cited by 2,055
Self-citationFeeder-free growth of undifferentiated human embryonic stem cells
Xu, C., Inokuma, M. S., Denham, J., Golds, K., Kundu, P., Gold, J. D., & Carpenter, M. K. (2001) · Nature Biotechnology · doi:10.1038/nbt1001-971 · Cited by 1,870
Chemically defined conditions for human iPSC derivation and culture
Chen, G., Gulbranson, D. R., Hou, Z., Bolin, J. M., Ruotti, V., Probasco, M. D., Smuga-Otto, K., Howden, S. E., Diol, N. R., Propson, N. E., et al. (2011) · Nature Methods · doi:10.1038/nmeth.1593 · Cited by 1,447 · cited 2×
“In addition, it is necessary to use defined culture system for the source of iPS cells, such as fibroblasts or blood cells 13,23 .”
BackgroundMethodEmbryonic stem cell trials for macular degeneration: a preliminary report
Schwartz, S. D., Hubschman, J.-P., Heilwell, G., Franco-Cardenas, V., Pan, C. K., Ostrick, R. M., Mickunas, E., Gay, R., Klimanskaya, I., & Lanza, R. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60028-2 · Cited by 1,409
Research works printed but not linked: 1
- Grigoriadis, A. E. et al. Directed differentiation of hematopoietic precursors and functional osteoclasts from human ES and iPS cells. Blood 115, 2769–2776 (2010). · DOI · Paper page
Cited by
Resetting Transcription Factor Control Circuitry toward Ground-State Pluripotency in Human
Takashima, Y., Guo, G., Loos, R., Nichols, J., Ficz, G., Krueger, F., Oxley, D., Santos, F., Clarke, J., Mansfield, W., et al. (2014) · Cell · doi:10.1016/j.cell.2014.08.029 · Cited by 952
“In these conditions, reset cells could form undifferentiated colonies on Matrigel or laminin 511-E8 (Nakagawa et al., 2014) (Figure 1K).”
BackgroundA decade of transcription factor-mediated reprogramming to pluripotency
Takahashi, K., & Yamanaka, S. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.8 · Cited by 878
Brain organoids: advances, applications and challenges
Qian, X., Song, H., & Ming, G.-L. (2019) · Development · doi:10.1242/dev.166074 · Cited by 724
“A shift to using feeder-free hPSC culture is likely to significantly improve reproducibility across laboratories and cell lines (Lancaster et al., 2017; Nakagawa et al., 2014; Yoon et al., 2019).”
BackgroundHuman iPS cell-derived dopaminergic neurons function in a primate Parkinson’s disease model
Kikuchi, T., Morizane, A., Doi, D., Magotani, H., Onoe, H., Hayashi, T., Mizuma, H., Takara, S., Takahashi, R., Inoue, H., et al. (2017) · Nature · doi:10.1038/nature23664 · Cited by 702
Self-citationTargeted Disruption of HLA Genes via CRISPR-Cas9 Generates iPSCs with Enhanced Immune Compatibility
Xu, H., Wang, B., Ono, M., Kagita, A., Fujii, K., Sasakawa, N., Ueda, T., Gee, P., Nishikawa, M., Nomura, M., et al. (2019) · Cell stem cell · doi:10.1016/j.stem.2019.02.005 · Cited by 581
Robust In Vitro Induction of Human Germ Cell Fate from Pluripotent Stem Cells
Sasaki, K., Yokobayashi, S., Nakamura, T., Okamoto, I., Yabuta, Y., Kurimoto, K., Ohta, H., Moritoki, Y., Iwatani, C., Tsuchiya, H., et al. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.06.014 · Cited by 551
Animal‐cell culture media: History, characteristics, and current issues
Yao, T., & Asayama, Y. (2017) · Reproductive Medicine and Biology · doi:10.1002/rmb2.12024 · Cited by 536
A developmental coordinate of pluripotency among mice, monkeys and humans
Nakamura, T., Okamoto, I., Sasaki, K., Yabuta, Y., Iwatani, C., Tsuchiya, H., Seita, Y., Nakamura, S., Yamamoto, T., & Saitou, M. (2016) · Nature · doi:10.1038/nature19096 · Cited by 526
A comparison of non-integrating reprogramming methods
Schlaeger, T. M., Daheron, L., Brickler, T. R., Entwisle, S., Chan, K., Cianci, A., DeVine, A., Ettenger, A., Fitzgerald, K., Godfrey, M., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3070 · Cited by 510
Induced Pluripotent Stem Cells and Their Use in Human Models of Disease and Development
Karagiannis, P., Takahashi, K., Saito, M., Yoshida, Y., Okita, K., Watanabe, A., Inoue, H., Yamashita, J. K., Todani, M., Nakagawa, M., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00039.2017 · Cited by 368
Co-ordinated ocular development from human iPS cells and recovery of corneal function
Hayashi, R., Ishikawa, Y., Sasamoto, Y., Katori, R., Nomura, N., Ichikawa, T., Araki, S., Soma, T., Kawasaki, S., Sekiguchi, K., et al. (2016) · Nature · doi:10.1038/nature17000 · Cited by 258
Plant and animal stem cells: similar yet different
Heidstra, R., & Sabatini, S. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3790 · Cited by 261
Generation of nephron progenitor cells and kidney organoids from human pluripotent stem cells
Morizane, R., & Bonventre, J. V. (2017) · Nature Protocols · doi:10.1038/nprot.2016.170 · Cited by 249
MHC matching improves engraftment of iPSC-derived neurons in non-human primates
Morizane, A., Kikuchi, T., Hayashi, T., Mizuma, H., Takara, S., Doi, H., Mawatari, A., Glasser, M. F., Shiina, T., Ishigaki, H., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00926-5 · Cited by 244
Sharmin, S., Taguchi, A., Kaku, Y., Yoshimura, Y., Ohmori, T., Sakuma, T., Mukoyama, M., Yamamoto, T., Kurihara, H., & Nishinakamura, R. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015010096 · Cited by 234
Iriguchi, S., Yasui, Y., Kawai, Y., Arima, S., Kunitomo, M., Sato, T., Ueda, T., Minagawa, A., Mishima, Y., Yanagawa, N., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20658-3 · Cited by 229
Recapitulating the human segmentation clock with pluripotent stem cells
Matsuda, M., Yamanaka, Y., Uemura, M., Osawa, M., Saito, M. K., Nagahashi, A., Nishio, M., Guo, L., Ikegawa, S., Sakurai, S., et al. (2020) · Nature · doi:10.1038/s41586-020-2144-9 · Cited by 206
Fukuta, M., Nakai, Y., Kirino, K., Nakagawa, M., Sekiguchi, K., Nagata, S., Matsumoto, Y., Yamamoto, T., Umeda, K., Heike, T., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112291 · Cited by 204
“987A3 hiPSCs were used as the initial material, which have been generated and maintained under feeder-free and xeno-free conditions [21].”
HLA-Matched Allogeneic iPS Cells-Derived RPE Transplantation for Macular Degeneration
Sugita, S., Mandai, M., Hirami, Y., Takagi, S., Maeda, T., Fujihara, M., Matsuzaki, M., Yamamoto, M., Iseki, K., Hayashi, N., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9072217 · Cited by 190
“We initially established iPSCs using non-integrating episomal vectors [23], with these cells subsequently differentiating into RPE cells [24].”
MethodKojima, Y., Sasaki, K., Yokobayashi, S., Sakai, Y., Nakamura, T., Yabuta, Y., Nakaki, F., Nagaoka, S., Woltjen, K., Hotta, A., et al. (2017) · Cell Stem Cell · doi:10.1016/j.stem.2017.09.005 · Cited by 185
Present and future challenges of induced pluripotent stem cells
Ohnuki, M., & Takahashi, K. (2015) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2014.0367 · Cited by 174
Feeder Layer Cell Actions and Applications
Llames, S., García-Pérez, E., Meana, Á., Larcher, F., & del Río, M. (2015) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2014.0547 · Cited by 163
Cold atmospheric plasma delivery for biomedical applications
Chen, Z., Chen, G., Obenchain, R. A., Zhang, R., Bai, F., Fang, T., Wang, H., Lu, Y., Wirz, R. E., & Gu, Z. (2022) · Materials Today · doi:10.1016/j.mattod.2022.03.001 · Cited by 181
Kawamura, T., Miyagawa, S., Fukushima, S., Maeda, A., Kashiyama, N., Kawamura, A., Miki, K., Okita, K., Yoshida, Y., Shiina, T., et al. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.01.012 · Cited by 145
“…(a gift from Professor Yamanaka), generated from an animal with a homozygous MHC haplotype as previously described (Okita et al., 2013). iPSCs were cultured using AK02 medium (Ajinomoto) on an LN511E8-coated (Nippi) dish as previously described (Miyazaki et al., 2012; Nakagawa et al., 2014).”
MethodSelf-citationTanigawa, S., Islam, M., Sharmin, S., Naganuma, H., Yoshimura, Y., Haque, F., Era, T., Nakazato, H., Nakanishi, K., Sakuma, T., et al. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.08.003 · Cited by 143
“These two clones were adapted to feederfree conditions (Nakagawa et al., 2014) and used for further studies.”
MethodIndana, D., Agarwal, P., Bhutani, N., & Chaudhuri, O. (2021) · Advanced Materials · doi:10.1002/adma.202101966 · Cited by 145
Yoshida, S., Kato, T. M., Sato, Y., Umekage, M., Ichisaka, T., Tsukahara, M., Takasu, N., & Yamanaka, S. (2023) · Med · doi:10.1016/j.medj.2022.10.003 · Cited by 134
Tu, H., Watanabe, T., Shirai, H., Yamasaki, S., Kinoshita, M., Matsushita, K., Hashiguchi, T., Onoe, H., Matsuyama, T., Kuwahara, A., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.11.028 · Cited by 140
“matrix (Nippi) in StemFit medium (Ajinomoto) according to the published protocol [21].”
MethodChang, C.-Y., Ting, H.-C., Liu, C.-A., Su, H.-L., Chiou, T.-W., Lin, S.-Z., Harn, H.-J., & Ho, T.-J. (2020) · Molecules · doi:10.3390/molecules25082000 · Cited by 133
Induced Pluripotent Stem Cells: Reprogramming Platforms and Applications in Cell Replacement Therapy
Al Abbar, A., Ngai, S. C., Nograles, N., Alhaji, S. Y., & Abdullah, S. (2020) · BioResearch Open Access · doi:10.1089/biores.2019.0046 · Cited by 134
“surface (known as the iMatrix-511 system) as a novel culture system with high efficiency for self-renewal of both human ESCs and human iPSCs.(111) Unfortunately, large-scale production and purification of biologically functioning recombinant laminins are laborious and costly.”
BackgroundOverview: An iPS cell stock at CiRA
Umekage, M., Sato, Y., & Takasu, N. (2019) · Inflammation and Regeneration · doi:10.1186/s41232-019-0106-0 · Cited by 122
N 1-Methylpseudouridine substitution enhances the performance of synthetic mRNA switches in cells
Parr, C. J. C., Wada, S., Kotake, K., Kameda, S., Matsuura, S., Sakashita, S., Park, S., Sugiyama, H., Kuang, Y., & Saito, H. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa070 · Cited by 120
“For partially differentiated iPSCs cultures, iPSCs were first differentiated for 7 days in StemFit without basic FGF according to protocol (11) and then seeded in 24-well plates in complete StemFit medium with 10 M ROCK inhibitor.”
MethodSC3-seq: a method for highly parallel and quantitative measurement of single-cell gene expression
Nakamura, T., Yabuta, Y., Okamoto, I., Aramaki, S., Yokobayashi, S., Kurimoto, K., Sekiguchi, K., Nakagawa, M., Yamamoto, T., & Saitou, M. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv134 · Cited by 120
“For this purpose, we generated singlecell cDNAs of two lines of hiPSCs (585A1 and 585B1) cultured on the SNL feeder cells and cultured under a feederfree condition (in total we generated 112 single-cell cDNAs of good quality) (Figure 6A and Supplementary Figure S6A and B) (23,25,26) and performed an SC3-seq analysis o…”
BackgroundMethodHigh molecular weight amyloid β 1‐42 oligomers induce neurotoxicity via plasma membrane damage
Yasumoto, T., Takamura, Y., Tsuji, M., Watanabe‐Nakayama, T., Imamura, K., Inoue, H., Nakamura, S., Inoue, T., Kimura, A., Yano, S., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201900604r · Cited by 120
“We performed tapping mode high-speed atomic force microscopy (HS-AFM) (25, 26) at room temperature in liquid using a small cantilever (BL-AC10-DS; Olympus, Tokyo, Japan) with HMW AMYLOID b1-42 OLIGOMERS INDUCE NEUROTOXICITY 9221 resonance frequency f of 400–500 kHz and a spring constant k of 0.1 N/m.”
MethodInfluentialMiyagawa, S., Kainuma, S., Kawamura, T., Suzuki, K., Ito, Y., Iseoka, H., Ito, E., Takeda, M., Sasai, M., Mochizuki‐Oda, N., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.950829 · Cited by 121
Hayashi, R., Ishikawa, Y., Katori, R., Sasamoto, Y., Taniwaki, Y., Takayanagi, H., Tsujikawa, M., Sekiguchi, K., Quantock, A. J., & Nishida, K. (2017) · Nature Protocols · doi:10.1038/nprot.2017.007 · Cited by 128
Hyvärinen, T., Hyysalo, A., Kapucu, F. E., Aarnos, L., Vinogradov, A., Eglen, S. J., Ylä-Outinen, L., & Narkilahti, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-53647-8 · Cited by 117
Inducible Transgene Expression in Human iPS Cells Using Versatile All-in-One piggyBac Transposons
Kim, S., Oceguera-Yañez, F., Sakurai, C., Nakagawa, M., Yamanaka, S., & Woltjen, K. (2015) · Methods in molecular biology · doi:10.1007/7651_2015_251 · Cited by 124
Purification of functional human ES and iPSC-derived midbrain dopaminergic progenitors using LRTM1
Samata, B., Doi, D., Nishimura, K., Kikuchi, T., Watanabe, A., Sakamoto, Y., Kakuta, J., Ono, Y., & Takahashi, J. B. (2016) · Nature Communications · doi:10.1038/ncomms13097 · Cited by 114
Lee, S., Huh, J. Y., Turner, D. M., Lee, S., Robinson, J., Stein, J. E., Shim, S. H., Hong, C. P., Kang, M. S., Nakagawa, M., et al. (2018) · Stem Cells · doi:10.1002/stem.2865 · Cited by 99
Desai, N., Rambhia, P., & Gishto, A. (2015) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-015-0005-4 · Cited by 98
“Nakagawa and colleagues reported better attachment of hESC and hiPSC dissociated in to single cells using StemFit media with laminin 511-E8 matrix [74].”
BackgroundMethodYamada, D., Iyoda, T., Vizcardo, R., Shimizu, K., Sato, Y., Endo, T. A., Kitahara, G., Okoshi, M., Kobayashi, M., Sakurai, M., et al. (2016) · Stem Cells · doi:10.1002/stem.2465 · Cited by 103
MicroRNA-302 switch to identify and eliminate undifferentiated human pluripotent stem cells
Parr, C., Katayama, S., Miki, K., Kuang, Y., Yoshida, Y., Morizane, A., Takahashi, J. B., Yamanaka, S., & Saito, H. (2016) · Scientific Reports · doi:10.1038/srep32532 · Cited by 96
Drozd, A. M., Walczak, M. P., Piaskowski, S., Stoczyńska-Fidelus, E., Rieske, P., & Grzela, D. P. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0112-3 · Cited by 101
The safety of human pluripotent stem cells in clinical treatment
Simonson, O. E., Domogatskaya, A., Volchkov, P., & Rodin, S. (2015) · Annals of Medicine · doi:10.3109/07853890.2015.1051579 · Cited by 97
Reorganization of 3D genome structure may contribute to gene regulatory evolution in primates
Eres, I. E., Luo, K., Hsiao, C. J., Blake, L. E., & Gilad, Y. (2019) · PLOS Genetics · doi:10.1371/journal.pgen.1008278 · Cited by 86
“We grew cells in feeder-free conditions [86] to approximately”
Miyazaki, T., Isobe, T., Nakatsuji, N., & Suemori, H. (2017) · Scientific Reports · doi:10.1038/srep41165 · Cited by 78
Regenerating human epithelia with cultured stem cells: feeder cells, organoids and beyond
Hynds, R. E., Bonfanti, P., & Janes, S. M. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201708213 · Cited by 86
“Laminin 511 has been used as a matrix for feeder-free growth of pluripotent (Nakagawa et al, 2014) and epithelial cells (Polisetti et al, 2017) but, overall, the physiological presentation of ECM secreted by cells seems to be more efficient compared with systems that use recombinant ECM proteins.”
BackgroundKawai, S., Yoshitomi, H., Sunaga, J., Alev, C., Nagata, S., Nishio, M., Hada, M., Koyama, Y., Uemura, M., Sekiguchi, K., et al. (2019) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0410-7 · Cited by 77
IGF1-mediated human embryonic stem cell self-renewal recapitulates the embryonic niche
Wamaitha, S. E., Grybel, K. J., Alanis‐Lobato, G., Gerri, C., Ogushi, S., McCarthy, A., Mahadevaiah, S. K., Healy, L. E., Lea, R. A., Molina‐Arcas, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14629-x · Cited by 78
Nakajima, T., Shibata, M., Nishio, M., Nagata, S., Alev, C., Sakurai, H., Toguchida, J., & Ikeya, M. (2018) · Development · doi:10.1242/dev.165431 · Cited by 88
“S2, various iPSC lines (201B7, TIG118-4f, 414C2, 409B2 and 1231A3) were used to examine the reproducibility of this study (Koyanagi-Aoi et al., 2013; Okita et al., 2011; Takahashi et al., 2007; Nakagawa et al., 2014).”
MethodERRγ enhances cardiac maturation with T-tubule formation in human iPSC-derived cardiomyocytes
Miki, K., Deguchi, K., Nakanishi-Koakutsu, M., Lucena-Cacace, A., Kondo, S., Fujiwara, Y., Hatani, T., Sasaki, M., Naka, Y., Okubo, C., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23816-3 · Cited by 76
Self-citationComprehensive update on inventory of finfish cell lines developed during the last decade (2010–2020)
Swaminathan, T. R., Narendrakumar, L., Geetha, P., Raja, S. A., Dharmaratnam, A., & Raj, N. S. (2021) · Reviews in Aquaculture · doi:10.1111/raq.12566 · Cited by 79
Kitano, Y., Nishimura, S., Kato, T., Ueda, A., Takigawa, K., Umekage, M., Nomura, M., Kawakami, A., Ogawa, H., Xu, H., et al. (2022) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2022.05.010 · Cited by 91
“The culture of iPSCs under feeder-free, xeno-free conditions was performed according to the methods of a previous study.(36) The methods of gene editing targeting the HLA-A/HLA-B/CIITA genes were described in a previous study, with a few modifications.”
Cell-mediated enzyme prodrug cancer therapies
Mooney, R., Majid, A. A., Batalla‐Covello, J., Annala, A. J., & Aboody, K. S. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.09.003 · Cited by 76
Clonal variation of human induced pluripotent stem cells for induction into the germ cell fate†
Yokobayashi, S., Okita, K., Nakagawa, M., Nakamura, T., Yabuta, Y., Yamamoto, T., & Saitou, M. (2017) · Biology of Reproduction · doi:10.1093/biolre/iox038 · Cited by 75
Generation of 3D lacrimal gland organoids from human pluripotent stem cells
Hayashi, R., Okubo, T., Kudo, Y., Ishikawa, Y., Imaizumi, T., Suzuki, K., Shibata, S., Katayama, T., Park, S., Young, R. D., et al. (2022) · Nature · doi:10.1038/s41586-022-04613-4 · Cited by 73
GATA transcription factors, SOX17 and TFAP2C, drive the human germ-cell specification program
Kojima, Y., Yamashiro, C., Murase, Y., Yabuta, Y., Okamoto, I., Iwatani, C., Tsuchiya, H., Nakaya, M., Tsukiyama, T., Nakamura, T., et al. (2021) · Life Science Alliance · doi:10.26508/lsa.202000974 · Cited by 76
A human iPS cell myogenic differentiation system permitting high-throughput drug screening
Uchimura, T., Otomo, J., Sato, M., & Sakurai, H. (2017) · Stem Cell Research · doi:10.1016/j.scr.2017.10.023 · Cited by 68
TALEN-mediated shift of mitochondrial DNA heteroplasmy in MELAS-iPSCs with m.13513G>A mutation
Yahata, N., Matsumoto, Y., Omi, M., Yamamoto, N., & Hata, R. (2017) · Scientific Reports · doi:10.1038/s41598-017-15871-y · Cited by 73
Methods of induced pluripotent stem cells for clinical application
Seki, T., & Fukuda, K. (2015) · World Journal of Stem Cells · doi:10.4252/wjsc.v7.i1.116 · Cited by 78
Chang, P.-H., Chao, H., Chern, E., & Hsu, S. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120575 · Cited by 70
Efficient genomic correction methods in human iPS cells using CRISPR–Cas9 system
Li, H. L., Gee, P., Ishida, K., & Hotta, A. (2016) · Methods · doi:10.1016/j.ymeth.2015.10.015 · Cited by 62
Development of stem cell-based therapy for Parkinson’s disease
Han, F., Baremberg, D., Gao, J., Duan, J., Lu, X., Zhang, N., & Chen, Q. (2015) · Translational Neurodegeneration · doi:10.1186/s40035-015-0039-8 · Cited by 72
“A recent study developed a feeder-free system to culture the hESCs and iPSCs in the StemFitTM medium, taking a big step toward making clinically-applicable GMP-standard cells [138].”
MethodKuang, Y., Miki, K., Parr, C., Hayashi, K., Takei, I., Li, J., Iwasaki, M., Nakagawa, M., Yoshida, Y., & Saito, H. (2017) · Cell chemical biology · doi:10.1016/j.chembiol.2017.04.010 · Cited by 65
Watari, K., Yamasaki, S., Tu, H., Shikamura, M., Kamei, T., Adachi, H., Tochitani, T., Kita, Y., Nakamura, A., Ueyama, K., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-04543-5 · Cited by 69
Ishii, T., Ishikawa, M., Fujimori, K., Maeda, T., Kushima, I., Arioka, Y., Mori, D., Nakatake, Y., Yamagata, B., Nio, S., et al. (2019) · eNeuro · doi:10.1523/eneuro.0403-18.2019 · Cited by 64
“…I disorder, the diagnosis was revised to bipolar II disorder because of the lack of severe manic episodes. iPSC generation and culture The 1210B2 (Nakagawa et al., 2014), 201B7 (Takahashi et al., 2007), WD39 (Imaizumi et al., 2012), 414C2 (Okita et al., 2011), eKA3 (Matsumoto et al., 2016),…”
BackgroundNakajima, T., Nakahata, A., Yamada, N., Yoshizawa, K., Kato, T., Iwasaki, M., Zhao, C., Kuroki, H., & Ikeya, M. (2021) · Nature Communications · doi:10.1038/s41467-021-25328-6 · Cited by 66
Nistor, P., May, P. W., Tamagnini, F., Randall, A. D., & Caldwell, M. A. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.04.050 · Cited by 70
Azuma, K., & Yamanaka, S. (2016) · Regenerative Therapy · doi:10.1016/j.reth.2016.01.009 · Cited by 63
Self-citationPennington, B. O., Clegg, D., Melkoumian, Z. K., & Hikita, S. T. (2015) · Stem Cells Translational Medicine · doi:10.5966/sctm.2014-0179 · Cited by 65
Sugai, K., Fukuzawa, R., Shofuda, T., Fukusumi, H., Kawabata, S., Nishiyama, Y., Higuchi, Y., Kawai, K., Isoda, M., Kanematsu, D., et al. (2016) · Molecular Brain · doi:10.1186/s13041-016-0265-8 · Cited by 64
“The 1210B2 and 1231A3 iPSCs were cultured with a feeder-free protocol [33], and the 1201C1 iPSCs were cultured with an on-feeder protocol that uses SNL feeder cells.”
MethodThe Molecular Karyotype of 25 Clinical-Grade Human Embryonic Stem Cell Lines
Canham, M. A., Deusen, A. L. V., Brison, D. R., Sousa, P. A. D., Downie, J. M., Devito, L., Hewitt, Z., Ilić, D., Kimber, S. J., Moore, H. D. M., et al. (2015) · Scientific Reports · doi:10.1038/srep17258 · Cited by 62
Cryopreservation of Adipose-Derived Mesenchymal Stem Cells
Miyagi‐Shiohira, C., Kurima, K., Kobayashi, N., Saitoh, I., Watanabe, M., Noguchi, Y., Matsushita, M., & Noguchi, H. (2015) · Cell Medicine · doi:10.3727/215517915x689100 · Cited by 60
“STEMCELLBANKER (cell banker 3) is a cell cryopreservation solution that satisfies the concept of a chemically defined known ingredient that is xeno-free and that optimizes the preservation performance of valuable cells such as somatic stem cells and induced pluripotent stem cells (27).”
BackgroundModeling Alexander disease with patient iPSCs reveals cellular and molecular pathology of astrocytes
Kondo, T., Funayama, M., Miyake, M., Tsukita, K., Era, T., Osaka, H., Ayaki, T., Takahashi, R., & Inoue, H. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0337-0 · Cited by 59
“…pluripotency, called induced pluripotent stem cells (iPSCs), has provided researchers with a revolutionary tool to study human biology and diseases [7]. iPSCs can be derived from many somatic cell types, including easily accessible dermal fibroblasts and peripheral blood mononuclear cells [8, 9].”
Yasuda, S.-Y., Ikeda, T., Shahsavarani, H., Yoshida, N., Nayer, B., Hino, M., Vartak-Sharma, N., Suemori, H., & Hasegawa, K. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0200-7 · Cited by 63
Human iPSC-liver organoid transplantation reduces fibrosis through immunomodulation
Tadokoro, T., Murata, S., Kato, M., Ueno, Y., Tsuchida, T., Okumura, A., Kuse, Y., Konno, T., Uchida, Y., Yamakawa, Y., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adg0338 · Cited by 58
Dual inhibition of TMPRSS2 and Cathepsin B prevents SARS-CoV-2 infection in iPS cells
Hashimoto, R., Sakamoto, A., Deguchi, S., Yi, R., Sano, E., Hotta, A., Takahashi, K., Yamanaka, S., & Takayama, K. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.10.016 · Cited by 58
Li, C. Y., Liang, Z., Hu, Y., Zhang, H., Setiasabda, K. D., Li, J., Ma, S., Xia, X., & Kuang, Y. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.10.003 · Cited by 61
“Besides common immortalized cell lines, human induced pluripotent stem cells 201B7 and its type-nonspecific differentiated cells (denoted as 201B7D14) were included as representatives of stem cells and differentiated somatic cells.(28,29) Even though these cell lines possessed different basal protein expression levels…”
Polisetti, N., Sorokin, L. M., Okumura, N., Koizumi, N., Kinoshita, S., Kruse, F. E., & Schlötzer-Schrehardt, U. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-04916-x · Cited by 61
Takada, S., Kambe, N., Kawasaki, Y., Niwa, A., Honda‐Ozaki, F., Kobayashi, K., Osawa, M., Nagahashi, A., Semi, K., Hotta, A., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.04.013 · Cited by 67
Arias, J., Yu, J., Varshney, M., Inzunza, J., & Nalvarte, I. (2021) · Stem Cells Translational Medicine · doi:10.1002/sctm.20-0459 · Cited by 57
“sion yield of human iPS cells has been greatly enhanced with the emergence of defined extracellular matrices such as vitronectin,(3) laminin 521,(4,12) and laminin 511.(13) These matrices enabled the transition”
BackgroundImproving Cell Recovery: Freezing and Thawing Optimization of Induced Pluripotent Stem Cells
Uhrig, M., Ezquer, F. E., & Ezquer, M. (2022) · Cells · doi:10.3390/cells11050799 · Cited by 62
Fujita, Y., Hirosawa, M., Hayashi, K., Hatani, T., Yoshida, Y., Yamamoto, T., & Saito, H. (2022) · Science Advances · doi:10.1126/sciadv.abj1793 · Cited by 61
Robust detection of undifferentiated iPSC among differentiated cells
Sekine, K., Tsuzuki, S., Yasui, R., Kobayashi, T., Ikeda, K., Hamada, Y., Kanai, E., Camp, J. G., Treutlein, B., Ueno, Y., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-66845-6 · Cited by 55
Akutsu, H., Machida, M., Kanzaki, S., Sugawara, T., Ohkura, T., Nakamura, N., Yamazaki‐Inoue, M., Miura, T., Vemuri, M. C., Rao, M. S., et al. (2015) · Regenerative Therapy · doi:10.1016/j.reth.2014.12.004 · Cited by 53
“reported a novel culture system for derivation and expansion of hiPSCs with the recombinant laminin-511 E8 fragment matrices and the xenogeneic-free culture medium (StemFitTM) [20].”
BackgroundSynthetic mRNA devices that detect endogenous proteins and distinguish mammalian cells
Kawasaki, S., Fujita, Y., Nagaike, T., Tomita, K., & Saito, H. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx298 · Cited by 53
“Human iPS cells (201B7, a kind gift from Dr Masato Nakagawa, Kyoto University) were cultured in feeder-free condition with StemFit AK03 (Ajinomoto) as previously described (21).”
Sougawa, N., Miyagawa, S., Fukushima, S., Kawamura, A., Yokoyama, J., Ito, E., Harada, A., Okimoto, K., Mochizuki-Oda, N., Saito, A., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-21923-8 · Cited by 54
Zandrini, T., Shan, O., Parodi, V., Cerullo, G., Raimondi, M. T., & Osellame, R. (2019) · Scientific Reports · doi:10.1038/s41598-019-48080-w · Cited by 58
The basement membrane in epidermal polarity, stemness, and regeneration
Rousselle, P., Laigle, C., & Rousselet, G. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00069.2022 · Cited by 70
Strategies for bringing stem cell-derived dopamine neurons to the clinic
Takahashi, J. B. (2017) · Progress in brain research · doi:10.1016/bs.pbr.2016.11.004 · Cited by 56
Hyysalo, A., Ristola, M., Mäkinen, M., Häyrynen, S., Nykter, M., & Narkilahti, S. (2017) · Stem Cell Research · doi:10.1016/j.scr.2017.09.002 · Cited by 53
“, 2014a) and further differentiation into dopaminergic neurons have also been reported on LN511-E8 (Doi et al., 2014;Nakagawa et al., 2014).”
BackgroundMethodYamasaki, S., Tu, H., Matsuyama, T., Horiuchi, M., Hashiguchi, T., Sho, J., Kuwahara, A., Kishino, A., Kimura, T., Takahashi, M., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103657 · Cited by 57
Iwashita, M., Ohta, H., Fujisawa, T., Cho, M., Ikeya, M., Kidoaki, S., & Kosodo, Y. (2019) · Scientific Reports · doi:10.1038/s41598-018-38395-5 · Cited by 60
Kashiyama, N., Miyagawa, S., Fukushima, S., Kawamura, T., Kawamura, A., Yoshida, S., Eiraku, S., Harada, A., Matsunaga, K., Watabe, T., et al. (2019) · Transplantation · doi:10.1097/tp.0000000000002765 · Cited by 52
Translational issues for human corneal endothelial tissue engineering
Soh, Y. Q., Peh, G. S. L., & Mehta, J. S. (2016) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2131 · Cited by 55
Biological effects of culture substrates on human pluripotent stem cells
Hayashi, Y., & Furue, M. K. (2016) · Stem Cells International · doi:10.1155/2016/5380560 · Cited by 50
“These fragments adhered to hESCs and hiPSCs better than Matrigel and intact laminin isoforms and sustained long-term self-renewal of hESCs and hiPSCs in defined xeno-free media (tested in mTeSR1 (Stem Cell Technologies), StemPro (Thermo Fisher Scientific), StemFit (Ajinomoto), and serum-free medium supplemented with N…”
Nakano-Kobayashi, A., Fukumoto, A., Morizane, A., Nguyen, D. T., Le, T. M., Hashida, K., Hosoya, T., Takahashi, R., Takahashi, J. B., Hori, O., et al. (2020) · Science Advances · doi:10.1126/sciadv.abc1428 · Cited by 52
“1039A1 iPS cells were established and maintained as described previously (41).”
BackgroundRay, A., Joshi, J. M., Sundaravadivelu, P. K., Raina, K., Lenka, N., Kaveeshwar, V., & Thummer, R. P. (2021) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10200-3 · Cited by 59
Single-cell transcriptome of early embryos and cultured embryonic stem cells of cynomolgus monkeys
Nakamura, T., Yabuta, Y., Okamoto, I., Sasaki, K., Iwatani, C., Tsuchiya, H., & Saitou, M. (2017) · Scientific Data · doi:10.1038/sdata.2017.67 · Cited by 47
Metadata
- Authors
- Nakagawa, M., Taniguchi, Y., Senda, S., Takizawa, N., Ichisaka, T., Asano, K., Morizane, A., Doi, D., Takahashi, J., Nishizawa, M., Yoshida, Y., Toyoda, T., Osafune, K., Sekiguchi, K., & Yamanaka, S.
- Affiliations
- Kyoto University (JP)
- Institute for Protein Research, The University of Osaka (JP)
- Ajinomoto (Japan) (JP)
- Gladstone Institutes (US)
- Corresponding author
- Nakagawa, Masato
- ORCID
- Venue
- Scientific Reports
- Published
- 2014-01-08
- Volume
- 4
- Issue
- 1
- Pages
- 3594-3594
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC3884228
- OpenAlex
- W1972564906
- Cited by
- 673
- References
- 30
- Citations by year
- 2026: 35 · 2025: 46 · 2024: 74 · 2023: 66 · 2022: 65 · 2021: 76 · 2020: 66 · 2019: 49 · 2018: 37 · 2017: 58 · 2016: 47 · 2015: 39 · 2014: 14
- FWCI
- 21.47
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/3.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/3.0/ (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion, cc-by-nc-nd)
- Institutional Repositories DataBase (IRDB) (submittedVersion)
- OUKA (Osaka University Knowledge Archive) (Osaka University) (submittedVersion)
- Kyoto University Research Information Repository (Kyoto University) (submittedVersion, cc-by-nc-nd)
- Funders
- Ministry of Education, Culture, Sports, Science and Technology
- Japan Society for the Promotion of Science (25860747, 24790277, 24590353, 24592124, 25291026)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Keywords
- induced pluripotent stem cells, feeder-free culture, xeno-free culture, human embryonic stem cells, primary fibroblasts, blood cells, karyotype stability, cell dissociation, differentiation potential
- MeSH terms
- Cell Differentiation, Culture Media, Humans, Serial Passage, Cell Culture Techniques, Induced Pluripotent Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.